论文部分内容阅读
目的探究多巴胺联合酚妥拉明用于肺心病难治性心衰患者治疗中的临床效果。方法从我院2014年4月至2015年4月收治的肺心病患者中抽取50例作为此次研究的对象,分为A、B组,每组各25例,A组采用多巴胺结合酚妥拉明治疗,B组采取常规治疗,比较两组患者的临床治疗效果。结果治疗后,A组肺心病难治性心衰患者治疗总有效率为92.0%;B组治疗总有效率为84.0%,A组患者的治疗总有效率明显高于B组(P<0.05),比较具体统计学意义。结论对肺心病难治性心衰患者采取多巴胺联合酚妥拉明治疗,能够有效提高治疗效率,促进患者尽快恢复,值得在临床上进一步推广及应用。
Objective To investigate the clinical effect of dopamine combined with phentolamine in the treatment of refractory heart failure patients with pulmonary heart disease. Methods Fifty patients with pulmonary heart disease admitted from April 2014 to April 2015 in our hospital were enrolled in this study. Patients were divided into groups A and B, with 25 cases in each group. Group A was treated with dopamine and phentolamine Ming treatment, B group to take conventional treatment, the clinical efficacy of the two groups were compared. Results After treatment, the total effective rate of treatment in patients with refractory heart failure in group A was 92.0%. The total effective rate in group B was 84.0%. The total effective rate in group A was significantly higher than that in group B (P <0.05) , More specific statistical significance. Conclusions Dopamine combined with phentolamine in patients with refractory heart failure of pulmonary heart disease can effectively improve the treatment efficiency and promote the recovery of patients as soon as possible, which is worth further promotion and application in clinic.